Add the Power of Expert Insights to Your Research. Learn More

LabCorp (NYSE: LH) Transcript Smart Summary Highlight: Delays in Trials and 50% Volume Drop Counter COVID-19 Testing Capacity Ramp

Today we continue our series on Q1 2020 Earnings Season, analyzing calls across a variety of industries using our machine learning and natural language call transcript application, Smart SummaryTM. Yesterday we looked at the logistics company, UPS (NYSE: UPS). Today we switch over to healthcare with LabCorp (NYSE: LH).

The LabCorp transcript we’re reviewing today was reported on April 29, 2020. As you can see below, the Smart Summary email came just a few minutes after the “old way” transcript (don’t worry, we have the full transcript in the Smart Summary too, with our NLP sentiment scoring applied).

The Smart Summary begins with a word cloud using NLP keyword surfacing on top of the new tearsheet. 

From the word cloud, we can quickly see that COVID-19 dominated the conversation, as is the case with the vast majority of the transcripts in Q1 2020. Serology is also related to COVID. We can also quickly spot Negative Impact, Adjusted Operating Income, and Drug Development—the company has some headwinds from trial delays. 

Overall sentiment is lower than prior quarters, but not like what we saw with UPS’s decidedly negative sentiment yesterday.

The ML-based Categories Heatmap is also more red than recent quarters across our broad ML classification categories. The increase in Deflection points to increased uncertainty versus the prior baseline. 

The top keywords, along with the top keywords over the last two years, are next in the emailed summary. We can see coronavirus and related terms (PCR and serology) dominate the call, along with “Negative Impact” and “Drug Development”. 

In the next section, we highlight several categories from the ML output, along with their sentiment scoring. The first category is Covid. 

In the top five Covid comments, we see the guidance withdrawal repeat (the company withdrew guidance in February) along with the client drug development program postponements. 

Business drivers are a mix of positive (i.e. share gains) and negative statements.

In the 10-min video below, we provide a more detailed walkthrough of the emailed Smart Summary along with the full version of the Smart Summary in the Sentieo platform, and check some of the data against the Smart Summary of LabCorp’s direct competitor, Quest (DGX).

Stay tuned for more highlights over the next week. You can register for our Q1 2020 Earnings Season Recap webinar on Thursday, May 7. And, if you would like to learn more about Sentieo’s ML and NLP capabilities, we’d be happy to schedule a demo